Richard S. Finkel - Concepedia

Author

Richard S. Finkel

Children's Hospital of Philadelphia ORCID

Also Known As

Basil T. Darras, Brenda Wong, Crystal J J Yeo, D De Vivo, Darryl De Vivo, Finkel, R, Finkel, Richard, G. Tennekoon, Iain Horrocks, Jean-Marie Cuisset

469

Publications

31.1K

Citations

H-Index

167

Concepts

All Affiliations

Children's Hospital of Philadelphia Nemours Children's Clinic University College London Boston Children's Hospital Columbia University Irving Medical Center

About

Richard S. Finkel is an author at Children's Hospital of Philadelphia specializing in medicine, rehabilitation, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	59	10K
2	Health Sciences	15	17	2.4K
3	Public Health	6	6	303
4	Social Sciences	3	3	87
5	Nursing	1	1	26

Richard S. Finkel

197

Publications

25.6K

Citations

H-Index

Page 1

	Year	Citations
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel, Eugenio Mercuri, Basil T. Darras, New England Journal of Medicine	2017	2.2K
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management K. Bushby, Richard S. Finkel, David J. Birnkrant, The Lancet Neurology Part 1KinesiologyPsychiatryDuchenne Muscular DystrophyDegenerative Disease	2009	2K
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga, New England Journal of Medicine	2018	1.4K
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study Richard S. Finkel, Claudia A. Chiriboga, Jiri Vajsar, The Lancet Dose-escalation StudySpinal Cord InjuryPediatric SpinePhase 2Neuromusculoskeletal Disorder	2016	998
Consensus Statement for Standard of Care in Spinal Muscular Atrophy Ching H. Wang, Richard S. Finkel, Enrico Bertini, Journal of Child Neurology Spine CarePrimary CareMedical TreatmentHealth SciencesCare Committee	2007	917
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics Richard S. Finkel, Eugenio Mercuri, Oscar H. Meyer, Neuromuscular Disorders Palliative CareSpine CareOther Organ SystemsSpinal Cord InjuryMedical Ethics	2017	642
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda, Neuromuscular Disorders Spinal DisorderPediatricsNurture StudySpinal Muscular AtrophyNeurology	2019	602
Agalsidase-Beta Therapy for Advanced Fabry Disease Maryam Banikazemi, Jan Bultas, Stephen Waldek, Annals of Internal Medicine	2007	564
Observational study of spinal muscular atrophy type I and implications for clinical trials Richard S. Finkel, Michael McDermott, Petra Kaufmann, Neurology	2014	506
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial John Day, Richard S. Finkel, Claudia A. Chiriboga, The Lancet Neurology Rare DiseasesSpinal Cord InjuryMedicineDegenerative DiseaseNeurology	2021	449

Page 1